Biocon Biologics has reached a settlement and licensing agreement with Regeneron, clearing the way for the US commercialization of Yesafili, its biosimilar to Eylea. The agreement allows Biocon ...

Assessing blood vessels at the back of the eye may one day become an accessible and cost-effective way to determine dementia risk. | Neuroscience ...

These preliminary results are based on management’s initial analysis of operations for the quarter ended March 29, 2025, and are subject to further internal review, potential adjustments and review by ...

Most patients in the United States who present to hospital emergency departments with acute central retinal artery occlusion do not undergo stroke workup imaging.

Eyestem Research announced positive results from its phase 1 trial ( NCT06394232) evaluating its investigational drug product ...

Pars plana vitrectomy is a safe and effective surgery that is essential in the treatment of a variety of posterior segment ...

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about what a retinal detachment is, including causes and symptoms.

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about Retinal Detachment Treatment - Pneumatic Retinoplexy ...

Volume 17, Issue 3, on March 4, 2025, titled “Deciphering age-related transcriptomic changes in the mouse retinal pigment epithelium.” ...

Researchers from the University of Otago have found a possible link between eye health and the risk of developing dementia.

While some medical concerns can wait for a regular appointment, others demand immediate attention to prevent serious complications or even save your life. Recognizing these critical situations can ...

Learn the main differences between liquid dispensing and metering and why this is key to achieving precise fluid management.